Rhyme Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -69.01%
- Profit Growth 1306.82%
- Ebitda 810.94%
- Net Worth 24.99%
- Total Assets -32.79%
About Rhyme Life Sciences
Rhyme Life Sciences Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2017 (Seven years and five months 4 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Parag Patil and Abhay Chimankar serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2017PTC299959
- Company No.
299959
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Rhyme Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parag Patil  | Director | 20-Sep-2017 | Current |
| Abhay Chimankar | Director | 20-Sep-2017 | Current |
Financial Performance of Rhyme Life Sciences.
Rhyme Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 69.01% decrease. The company also saw a substantial improvement in profitability, with a 1306.82% increase in profit. The company's net worth Soared by an impressive increase of 24.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rhyme Life Sciences?
Unlock access to Rhyme Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cadence Life Sciences LlpAbhay Chimankar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rhyme Life Sciences?
Unlock and access historical data on people associated with Rhyme Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rhyme Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhyme Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.